Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor
暂无分享,去创建一个
Dian Feng | E. Manseau | H. Dvorak | J. Krieger | R. Mulligan | J. Nagy | A. Dvorak | L. Brown | V. Harvey | E. Morgan | C. Sundberg | Anna Pettersson | Janice A Nagy | Lawrence F Brown | Christian Sundberg | Ellen Morgan | Steven Jungles | Robert Carter | Jose E Krieger | Eleanor J Manseau | V Susan Harvey | Isabelle A Eckelhoefer | Ann M Dvorak | Richard C Mulligan | Harold F Dvorak | D. Feng | I. A. Eckelhoefer | S. Jungles | A. Pettersson | R. Carter | Harold F Dvorak | Eleanor J Manseau | Isabelle A Eckelhoefer | Janice A Nagy | Lawrence F Brown | Jose E Krieger | V Susan Harvey | Ann M Dvorak | Richard C Mulligan | Dian Feng | J. Krieger
[1] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[2] J. Pearlman,et al. VEGF administration in chronic myocardial ischemia in pigs. , 1998, Cardiovascular research.
[3] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[4] H. Kleinman,et al. Regulation of capillary formation by laminin and other components of the extracellular matrix. , 1997, EXS.
[5] K Walsh,et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. , 1998, Circulation.
[6] H. Dvorak,et al. Reinterpretation of endothelial cell gaps induced by vasoactive mediators in guinea‐fig, mouse and rat: many are transcellular pores , 1997, The Journal of physiology.
[7] Takayuki Asahara,et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.
[8] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. , 1997, EXS.
[9] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[10] I. Buschmann,et al. Arteriogenesis Versus Angiogenesis: Two Mechanisms of Vessel Growth. , 1999, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[11] H. Dvorak,et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.
[12] J D Pearlman,et al. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. , 1998, The Annals of thoracic surgery.
[13] J. Mulliken,et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. , 1994, The Journal of clinical investigation.
[14] J. Isner,et al. Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Clinical Investigation and Reports , 1998 .
[15] H. Dvorak,et al. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis , 1994, The Journal of experimental medicine.
[16] M. Kitamura,et al. Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.
[17] R. Crystal,et al. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. , 1998, Journal of vascular surgery.
[18] J. Isner,et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. , 1996, Biochemical and biophysical research communications.
[19] H. Blau,et al. VEGF gene delivery to muscle: potential role for vasculogenesis in adults. , 1998, Molecular cell.
[20] F. Sellke,et al. Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity. , 1998, Microvascular research.
[21] H. Dvorak,et al. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. , 1996, The American journal of pathology.
[22] P. Colville-Nash,et al. Growth factors in angiogenesis: current interest and therapeutic potential. , 1997, Molecular medicine today.
[23] T. Henry. Can we really grow new blood vessels? , 1998, The Lancet.
[24] J. Isner,et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. , 1998, Circulation.
[25] J. Hallervorden. [Tumors of the nervous system]. , 1951, Strahlentherapie.
[26] J. Isner,et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.
[27] T. Skalak,et al. Where Do New Arterioles Come From? Mechanical Forces and Microvessel Adaptation , 1998, Microcirculation.
[28] Robert E. Sandstrom,et al. Pathology of the Skin With Clinical Correlations , 1990 .
[29] M. Berman. Proliferative Hemangiomas: Analysis of Cytokine Gene Expression and Angiogenesis , 1999 .
[30] J. Isner,et al. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. , 1998, The American journal of pathology.
[31] R K Jain,et al. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. , 1996, The American journal of pathology.
[32] L. Brown,et al. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. , 1996, The American journal of physiology.
[33] J. Folkman,et al. Angiogenesis and angiogenesis inhibition: an overview. , 1997, EXS.
[34] H. Dvorak,et al. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels. , 2000, Microvascular research.
[35] Henrt Sharp. VASCULAR BIRTHMARKS , 1953, The Medical journal of Australia.
[36] J. Isner,et al. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. , 1995, The American journal of pathology.
[37] J. Isner,et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. , 1998, Journal of vascular surgery.
[38] E. Edelman,et al. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. , 1997, The Journal of pharmacology and experimental therapeutics.
[39] W. Schaper. Angiogenesis in the adult heart. , 1991, Basic research in cardiology.
[40] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[41] Mojmir R Tarek,et al. A novel mechanism of capillary growth in the rat pulmonary microcirculation , 1990, The Anatomical record.
[42] R. Crystal,et al. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. , 1993, Circulation research.
[43] R. Mulligan,et al. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[44] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[45] E. Manseau,et al. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. , 1995, Cancer research.
[46] M. Cohen. Coronary collaterals : clinical & experimental observations , 1985 .
[47] S. Paku,et al. First steps of tumor-related angiogenesis. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[48] J. Isner,et al. Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. , 1994, The American journal of physiology.
[49] M. Desjardins,et al. Heterogenous distribution of type IV collagen, entactin, heparan sulfate proteoglycan, and laminin among renal basement membranes as demonstrated by quantitative immunocytochemistry. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[50] Harold E. Dvorak,et al. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin , 1996, The Journal of experimental medicine.
[51] L. Orci,et al. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. , 1991, Biochemical and biophysical research communications.
[52] Hans-Inge Peterson,et al. Tumor Blood Circulation: Angiogenesis, Vascular Morphology and Blood Flow of Experimental and Human Tumors , 1979 .
[53] D. Hanahan. A flanking attack on cancer , 1998, Nature Medicine.
[54] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[55] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[56] E. Bauer,et al. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells , 1992, Journal of cellular physiology.
[57] L. Cantley,et al. Vascular Dysmorphogenesis Caused by an Activating Mutation in the Receptor Tyrosine Kinase TIE2 , 1996, Cell.
[58] H. Dvorak,et al. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. , 1988, The American journal of pathology.
[59] J. Pearlman,et al. Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis , 1995, Nature Medicine.
[60] R. Crystal,et al. Regional angiogenesis induced in nonischemic tissue by an adenoviral vector expressing vascular endothelial growth factor. , 1997, Human gene therapy.
[61] Peipei Ping,et al. Intracoronary gene transfer of fibroblast growth factor–5 increases blood flow and contractile function in an ischemic region of the heart , 1996, Nature Medicine.
[62] Itzhak D. Goldberg,et al. Regulation of Angiogenesis , 1996, Experientia Supplementum.
[63] C. Little,et al. Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[64] H. Dvorak,et al. The vesiculo‐vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation , 1996, Journal of leukocyte biology.
[65] J. Isner,et al. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. , 1999, The Journal of clinical investigation.
[66] W. Aird,et al. Vascular Bed–specific Expression of an Endothelial Cell Gene Is Programmed by the Tissue Microenvironment , 1997, The Journal of cell biology.
[67] D. Bergel,et al. Distensibility of single capillaries and venules in the rat and frog mesentery. , 1989, International journal of microcirculation, clinical and experimental.
[68] F. Sellke,et al. Modulation of myocardial perfusion and vascular reactivity by pericardial basic fibroblast growth factor: insight into ischemia-induced reduction in endothelium-dependent vasodilatation. , 1998, The Journal of thoracic and cardiovascular surgery.
[69] J. Ware,et al. Angiogenesis in ischemic heart disease , 1997, Nature Medicine.
[70] R. Warren,et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. , 1995, The Journal of clinical investigation.
[71] E. Manseau,et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. , 1993, Cancer research.